Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary stenting of occluded native coronary arteries II--rationale and design of the PRISON II study: a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions.
Rahel BM, Laarman GJ, Suttorp MJ; PRISON II study investigators. Rahel BM, et al. Among authors: laarman gj. Am Heart J. 2005 Mar;149(3):e1-3. doi: 10.1016/j.ahj.2004.10.027. Am Heart J. 2005. PMID: 15864219
Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions.
Suttorp MJ, Laarman GJ, Rahel BM, Kelder JC, Bosschaert MA, Kiemeneij F, Ten Berg JM, Bal ET, Rensing BJ, Eefting FD, Mast EG. Suttorp MJ, et al. Among authors: laarman gj. Circulation. 2006 Aug 29;114(9):921-8. doi: 10.1161/CIRCULATIONAHA.106.613588. Epub 2006 Aug 14. Circulation. 2006. PMID: 16908768 Clinical Trial.
Outpatient coronary angioplasty: feasible and safe.
Slagboom T, Kiemeneij F, Laarman GJ, van der Wieken R. Slagboom T, et al. Among authors: laarman gj. Catheter Cardiovasc Interv. 2005 Apr;64(4):421-7. doi: 10.1002/ccd.20313. Catheter Cardiovasc Interv. 2005. PMID: 15789393 Clinical Trial.
Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.
Dirksen MT, Ronner E, Laarman GJ, van Heerebeek L, Slagboom T, van der Wieken LR, van der Wouw PA, Kiemeneij F. Dirksen MT, et al. Among authors: laarman gj. J Invasive Cardiol. 2005 Oct;17(10):512-7. J Invasive Cardiol. 2005. PMID: 16204742 Clinical Trial.
118 results